IGLV3-27

Chr 22

immunoglobulin lambda variable 3-27

Also known as: IGLV327, V2-19

Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Jul 2025]

35
ClinVar variants
21
Pathogenic / LP
pLI score
0
Active trials
Clinical SummaryIGLV3-27
📋
ClinVar Variants
21 Pathogenic / Likely Pathogenic· 12 VUS of 35 total submissions

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

35 submitted variants in ClinVar

Classification Summary

Pathogenic19
Likely Pathogenic2
VUS12
Likely Benign1
Benign1
19
Pathogenic
2
Likely Pathogenic
12
VUS
1
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
19
Likely Pathogenic
2
VUS
12
Likely Benign
1
Benign
1
Total35

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

IGLV3-27 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Clinical Literature
Landmark / reviewRecent case evidence

No publications found for IGLV3-27

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →